Sofya Tokman

1.2k total citations
44 papers, 390 citations indexed

About

Sofya Tokman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Sofya Tokman has authored 44 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Epidemiology. Recurrent topics in Sofya Tokman's work include Transplantation: Methods and Outcomes (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Sofya Tokman is often cited by papers focused on Transplantation: Methods and Outcomes (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Sofya Tokman collaborates with scholars based in United States, Australia and Switzerland. Sofya Tokman's co-authors include Kellie J. Goodlet, Michael D. Nailor, Rajat Walia, Sunwen Chou, Thalachallour Mohanakumar, Ross M. Bremner, Laurence Huang, A. Arjuna, Steven R. Hays and Jonathan P. Singer and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Sofya Tokman

36 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofya Tokman United States 10 175 137 110 58 57 44 390
Tammy Ojo United States 8 282 1.6× 145 1.1× 146 1.3× 16 0.3× 152 2.7× 11 507
Elisa Gabanti Italy 12 171 1.0× 47 0.3× 79 0.7× 32 0.6× 72 1.3× 23 372
Chien‐Li Holmes‐Liew Australia 11 226 1.3× 116 0.8× 127 1.2× 12 0.2× 86 1.5× 26 408
Richard D. Cornwell United States 11 211 1.2× 246 1.8× 223 2.0× 26 0.4× 83 1.5× 21 531
D. Lyu United States 10 127 0.7× 228 1.7× 80 0.7× 24 0.4× 94 1.6× 30 390
Constance M. Mobley United States 10 72 0.4× 293 2.1× 128 1.2× 25 0.4× 106 1.9× 27 497
J Prop Netherlands 11 111 0.6× 235 1.7× 117 1.1× 28 0.5× 18 0.3× 33 414
M. de la Torre Spain 12 132 0.8× 200 1.5× 61 0.6× 20 0.3× 67 1.2× 32 338
Miguel M. Leiva‐Juárez United States 9 85 0.5× 79 0.6× 95 0.9× 61 1.1× 56 1.0× 22 322
Saskia Gruber Austria 12 53 0.3× 95 0.7× 42 0.4× 13 0.2× 22 0.4× 37 352

Countries citing papers authored by Sofya Tokman

Since Specialization
Citations

This map shows the geographic impact of Sofya Tokman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofya Tokman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofya Tokman more than expected).

Fields of papers citing papers by Sofya Tokman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofya Tokman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofya Tokman. The network helps show where Sofya Tokman may publish in the future.

Co-authorship network of co-authors of Sofya Tokman

This figure shows the co-authorship network connecting the top 25 collaborators of Sofya Tokman. A scholar is included among the top collaborators of Sofya Tokman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofya Tokman. Sofya Tokman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodlet, Kellie J., Michael D. Nailor, & Sofya Tokman. (2025). P-2274. Incidence and Microbiology of Postoperative Pleural Space Infections among Lung Transplant Recipients. Open Forum Infectious Diseases. 12(Supplement_1).
2.
3.
Chang, Young‐Tae, et al.. (2025). Atypical Presentation of Recurrent Diffuse Large B-cell Lymphoma in a Lung Transplant Recipient. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7536–A7536.
4.
Nailor, Michael D., et al.. (2024). Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious Disease. 26(3). e14279–e14279. 5 indexed citations
5.
Bay, R. Curtis, et al.. (2024). Clinical utility of plasma percent donor-derived cell-free DNA for lung allograft surveillance: A real-world single-center experience. SHILAP Revista de lepidopterología. 6. 100141–100141. 1 indexed citations
6.
7.
Walia, Rajat, et al.. (2024). Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience. SHILAP Revista de lepidopterología. 3. 1408289–1408289. 1 indexed citations
8.
Ravichandran, Ranjithkumar, Timothy P. Fleming, Stephen G. Wheatcroft, et al.. (2023). Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis. Cell Reports Medicine. 4(3). 100945–100945. 42 indexed citations
9.
Bansal, Sandhya, Timothy P. Fleming, Gabriel N. Maine, et al.. (2023). Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity. Transplant Immunology. 81. 101940–101940.
10.
Bay, R. Curtis, A. Arjuna, Hesham Mohamed, et al.. (2023). Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience. The Journal of Heart and Lung Transplantation. 43(3). 442–452. 6 indexed citations
11.
12.
Hu, Chengcheng, et al.. (2022). Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients. Transplant Immunology. 75. 101703–101703. 3 indexed citations
13.
Bansal, Sandhya, A. Arjuna, Sudhir Perincheri, et al.. (2021). Restrictive allograft syndrome vs bronchiolitis obliterans syndrome: Immunological and molecular characterization of circulating exosomes. The Journal of Heart and Lung Transplantation. 41(1). 24–33. 12 indexed citations
14.
Sharma, Monal, Muthukumar Gunasekaran, Ranjithkumar Ravichandran, et al.. (2020). Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis. The Journal of Heart and Lung Transplantation. 39(11). 1210–1219. 30 indexed citations
15.
Rahman, Mohammad Aminur, Angara Sureshbabu, Sofya Tokman, & Thalachallour Mohanakumar. (2019). Chronic Lung Allograft Dysfunction: Immune Responses Induced by Circulating Exosomes with Lung-Associated Self-Antigens. Critical Reviews in Immunology. 39(2). 123–134. 3 indexed citations
16.
Goodlet, Kellie J., et al.. (2018). Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection. American Journal of Transplantation. 18(12). 3060–3064. 98 indexed citations
17.
Tokman, Sofya, et al.. (2016). Lung Transplant Recipient with Pulmonary Alveolar Proteinosis. SHILAP Revista de lepidopterología. 2016. 1–4. 9 indexed citations
18.
Tokman, Sofya, Jonathan P. Singer, Megan Devine, et al.. (2015). Clinical outcomes of lung transplant recipients with telomerase mutations. The Journal of Heart and Lung Transplantation. 34(10). 1318–1324. 65 indexed citations
19.
Tokman, Sofya, Christopher F. Barnett, Leah G. Jarlsberg, et al.. (2014). Procalcitonin predicts mortality in HIV‐infected U gandan adults with lower respiratory tract infections. Respirology. 19(3). 382–388. 11 indexed citations
20.
Tokman, Sofya, Philipp Schüetz, & Stephen Bent. (2011). Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations. Expert Review of Anti-infective Therapy. 9(6). 727–735. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tammy Ojo Breakdown of academic impact, for papers by Elisa Gabanti Breakdown of academic impact, for papers by Chien‐Li Holmes‐Liew Breakdown of academic impact, for papers by Richard D. Cornwell Breakdown of academic impact, for papers by D. Lyu Breakdown of academic impact, for papers by Constance M. Mobley Breakdown of academic impact, for papers by J Prop Breakdown of academic impact, for papers by M. de la Torre Breakdown of academic impact, for papers by Miguel M. Leiva‐Juárez Breakdown of academic impact, for papers by Saskia Gruber
Rankless by CCL
2026